About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Biotech Class of the Early 90s | Main | Benlysta's Adventures In the Real World »

May 4, 2012

GSK with AstraZeneca?

Email This Entry

Posted by Derek

Here's a Reuters headline for you: "GSK rejects idea of buying AstraZeneca".

In other news, Delta Airlines has rejected the idea of making its new fleet of long-range passenger jets out of bamboo and stale Fig Newton bars. There are also reports this morning that Burger King has rejected the idea of buying Birkenstock and cramming their sandals into buns in lieu of hamburger patties. More business news as it become available.

Comments (18) + TrackBacks (0) | Category: Business and Markets


1. PPedroso on May 4, 2012 6:33 AM writes...


I also reject the idea of buying AstraZeneca.


Permalink to Comment

2. Ricardo Rodriges on May 4, 2012 6:40 AM writes...

Now, american airlines buying AZ, that would be a headline I would like to read, couldn't mismanage much more the company ... well, better not to give them a challenge :-D

Permalink to Comment

3. Nick K on May 4, 2012 6:46 AM writes...

Thank you Derek, made my day!

Permalink to Comment

4. schinderhannes on May 4, 2012 6:54 AM writes...

With Burger King, the customers wouldn´t notice the difference!

Permalink to Comment

5. CR on May 4, 2012 7:30 AM writes...

A related story, but I'm sure it's one you're following: "With his recent (failed) attempt at humor, noted bloggist Dr. Lowe has rejected the idea of becoming a humor columnist."

Permalink to Comment

6. partial agonist on May 4, 2012 8:04 AM writes...


Any thoughts on the Nature paper on pyroglutamylated (or pyroglu) beta-amyloid as the "real bad guy" in Alzheimer’s disease?

Permalink to Comment

7. johnnyboy on May 4, 2012 8:42 AM writes...

Sure the idea seems fanciful these days, but not more than 3 years ago it would have seemed perfectly rational - at least to business journalists, merger lawyers and CEOs.

Permalink to Comment

8. Anonymous on May 4, 2012 10:27 AM writes...

Derek, they're just called Newtons now -- not Fig Newtons. Or did you miss today's today's other big headline:

Permalink to Comment

9. Paul on May 4, 2012 2:15 PM writes...

So #8, if I make an impulse purchase of more cookies, the correct unit of measurement would be newton-seconds?

Permalink to Comment

10. Joel on May 4, 2012 3:43 PM writes...

In other news, the Huffington Post has ruled out buying In The Pipeline. “Getting involved with real facts would be too much of a distraction,” said Huffer-in-chief Arianna Huffington.

Permalink to Comment

11. Fred on May 5, 2012 7:40 AM writes...

News Flash: GSK demonstrates good judgment for once.

Permalink to Comment

12. Vim on May 5, 2012 2:03 PM writes...

A truly damning verdict on AZ. My thoughts and best wishes go out to all its employees left watching as Brennan slinks off with suitcases stuffed with cash. I heard he cut 31,000 during his reign - to achieve what precisely?

Permalink to Comment

13. Sweden Calling on May 5, 2012 3:37 PM writes...

We (as in AZ) are not interested in buying GSK either. ; )

Permalink to Comment

14. Anonymous on May 5, 2012 7:02 PM writes...

Well, GSK bought Sirtris... Doh!! I wouldn't be surprised if they actually buy AZ in the end. After all, management lies and tries to hide their real intentions. We are in for some serious "consolidation" in big pharma in the next 1-2 yrs. Watch out AZ, you have no future. In the end I see Pfizer, GSK and Novartis as the players in big pharma. The others will be consumed....and their bones (employees) will fall victim. Beware my friends...take shelter...

Permalink to Comment

15. anonymous on May 6, 2012 5:30 PM writes...

Do you really see Merck as gone???? I think NOT!

Permalink to Comment

16. pandora on May 6, 2012 9:00 PM writes...

mind you that GSK was answering a question brought up
by someone.

Permalink to Comment

17. Vim on May 7, 2012 5:47 AM writes...

Keep an eye out for the 5 words that have foreshadowed the end of many a country's industrial base: "creation of a national champion".

Permalink to Comment

18. timmy on May 7, 2012 9:52 AM writes...


Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry